US FDA Clarifies Populations And Anti-Infective Indications Eligible For Approval Under LPAD

 
• By Sue Sutter
  
Outdoor view of a narrow pathway covered by gravel in a public garden. Leading way limited by green scrubs and branches. Natural image in a french park.
US FDA has finalized its guidance on implementation of the limited population pathway. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Review Pathways

More from Pathways & Standards